PMC:7211620 / 9990-10239 JSONTXT

Annnotations TAB JSON ListView MergeView

    LitCovid-PD-FMA-UBERON

    {"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T35","span":{"begin":58,"end":63},"obj":"Body_part"}],"attributes":[{"id":"A35","pred":"fma_id","subj":"T35","obj":"http://purl.org/sig/ont/fma/fma63083"}],"text":"Recently, in the influenza and aspergillosis trial, GM in serum and bronchoalveolar lavage fluid was added to the ICU criteria as an additional mycological criterium to overcome the limitation of imperfect culture sensitivity for aspergillosis [15]."}

    LitCovid-PD-UBERON

    {"project":"LitCovid-PD-UBERON","denotations":[{"id":"T26","span":{"begin":58,"end":63},"obj":"Body_part"}],"attributes":[{"id":"A26","pred":"uberon_id","subj":"T26","obj":"http://purl.obolibrary.org/obo/UBERON_0001977"}],"text":"Recently, in the influenza and aspergillosis trial, GM in serum and bronchoalveolar lavage fluid was added to the ICU criteria as an additional mycological criterium to overcome the limitation of imperfect culture sensitivity for aspergillosis [15]."}

    LitCovid-PD-MONDO

    {"project":"LitCovid-PD-MONDO","denotations":[{"id":"T77","span":{"begin":17,"end":26},"obj":"Disease"},{"id":"T78","span":{"begin":31,"end":44},"obj":"Disease"},{"id":"T79","span":{"begin":230,"end":243},"obj":"Disease"}],"attributes":[{"id":"A77","pred":"mondo_id","subj":"T77","obj":"http://purl.obolibrary.org/obo/MONDO_0005812"},{"id":"A78","pred":"mondo_id","subj":"T78","obj":"http://purl.obolibrary.org/obo/MONDO_0005657"},{"id":"A79","pred":"mondo_id","subj":"T79","obj":"http://purl.obolibrary.org/obo/MONDO_0005657"}],"text":"Recently, in the influenza and aspergillosis trial, GM in serum and bronchoalveolar lavage fluid was added to the ICU criteria as an additional mycological criterium to overcome the limitation of imperfect culture sensitivity for aspergillosis [15]."}

    LitCovid-PD-CHEBI

    {"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T82","span":{"begin":52,"end":54},"obj":"Chemical"}],"attributes":[{"id":"A82","pred":"chebi_id","subj":"T82","obj":"http://purl.obolibrary.org/obo/CHEBI_74120"}],"text":"Recently, in the influenza and aspergillosis trial, GM in serum and bronchoalveolar lavage fluid was added to the ICU criteria as an additional mycological criterium to overcome the limitation of imperfect culture sensitivity for aspergillosis [15]."}

    LitCovid-sentences

    {"project":"LitCovid-sentences","denotations":[{"id":"T79","span":{"begin":0,"end":249},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Recently, in the influenza and aspergillosis trial, GM in serum and bronchoalveolar lavage fluid was added to the ICU criteria as an additional mycological criterium to overcome the limitation of imperfect culture sensitivity for aspergillosis [15]."}

    LitCovid-PubTator

    {"project":"LitCovid-PubTator","denotations":[{"id":"311","span":{"begin":17,"end":26},"obj":"Species"},{"id":"312","span":{"begin":52,"end":54},"obj":"Chemical"},{"id":"314","span":{"begin":31,"end":44},"obj":"Disease"},{"id":"315","span":{"begin":230,"end":243},"obj":"Disease"}],"attributes":[{"id":"A311","pred":"tao:has_database_id","subj":"311","obj":"Tax:11308"},{"id":"A312","pred":"tao:has_database_id","subj":"312","obj":"MESH:D005839"},{"id":"A314","pred":"tao:has_database_id","subj":"314","obj":"MESH:D001228"},{"id":"A315","pred":"tao:has_database_id","subj":"315","obj":"MESH:D001228"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Recently, in the influenza and aspergillosis trial, GM in serum and bronchoalveolar lavage fluid was added to the ICU criteria as an additional mycological criterium to overcome the limitation of imperfect culture sensitivity for aspergillosis [15]."}

    2_test

    {"project":"2_test","denotations":[{"id":"32395423-30076119-68941096","span":{"begin":245,"end":247},"obj":"30076119"}],"text":"Recently, in the influenza and aspergillosis trial, GM in serum and bronchoalveolar lavage fluid was added to the ICU criteria as an additional mycological criterium to overcome the limitation of imperfect culture sensitivity for aspergillosis [15]."}